Evidence map›Paper›PMID 41908262›Full record

ArticleResearch methods in medicine & health sciences2022

The PROMoting the USE of SWATs (PROMETHEUS) programme: Lessons learnt and future developments for SWATs.

Laura Clark, Catherine Arundel, Elizabeth Coleman, Laura Doherty, Adwoa Parker, Catherine Hewitt, David Beard, Peter Bower, Paul Brocklehurst, Cindy Cooper and 10 more

Abstract read
In one paragraph

Article in Research methods in medicine & health sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Laura ClarkYork Trials Unit, Department of Health Sciences, University of York, York, UK.ORCID https://orcid.org/0000-0001-9227-5447
Catherine ArundelYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Elizabeth ColemanYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Laura DohertyYork Trials Unit, Department of Health Sciences, University of York, York, UK.ORCID https://orcid.org/0000-0001-5310-5808
Adwoa ParkerYork Trials Unit, Department of Health Sciences, University of York, York, UK.ORCID https://orcid.org/0000-0002-2880-3935
Catherine HewittYork Trials Unit, Department of Health Sciences, University of York, York, UK.
David BeardNuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Science, NIHR Biomedical Research Unit, University of Oxford, Oxford, UK.
Peter BowerNational Institute for Health Research School for Primary Care Research, Centre for Primary Care and Health Services Research, University of Manchester, Manchester, UK.
Paul BrocklehurstBangor University, Gwynedd, UK.
Cindy CooperSchool of Health and Related Research, University of Sheffield, Sheffield, UK.
Lucy CullifordBristol Trials Centre, Clinical Trials and Evaluation Unit, University of Bristol, Bristol, UK.
Declan DevaneSchool of Nursing and Midwifery, National University of Galway, Galway, Ireland.
Richard EmsleyDepartment of Biostatistics and Health Informatics, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
Sandra EldridgeInstitute of Population Health Sciences, Queen Mary University of London, London, UK.
Sandra GalvinSchool of Nursing and Midwifery, National University of Galway, Galway, Ireland.
Katie GilliesHealth Services Research Unit, University of Aberdeen, Health Sciences Building, Foresthill Aberdeen, Aberdeen, UK.
Alan MontgomeryNottingham Clinical Trials Unit, University of Nottingham, Nottinghamshire, UK.
Chris SuttonSchool of Health Sciences, University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-6406-1318
Shaun TreweekHealth Services Research Unit, University of Aberdeen, Health Sciences Building, Foresthill Aberdeen, Aberdeen, UK.
David TorgersonYork Trials Unit, Department of Health Sciences, University of York, York, UK.ORCID https://orcid.org/0000-0002-1667-4275

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The PROMETHEUS programme (PROMoting THE USE of SWATs) was funded by the UK Medical Research Council (MRC) and Clinical Trials Unit (CTU) infrastructure funding from the National Institute for Health Research (NIHR). The purpose was to develop strategies to increase the recruitment and retention evidence base. This paper aims to present observations from this work. Observations: The PROMETHUS programme funded 42 SWATs, the average cost of each SWAT was £4007. A central coordination point enabled a concentrated effort in SWAT research activity leading to a rapid increase in the evidence base. The methodological feasibility of undertaking a coordinated SWAT design was established. The international Trial Forge SWAT Network was developed in 2021 to connect research groups in response for the need to connect teams undertaking methodological research. A SWAT reporting template and a database of researchers willing to peer review SWATs are also needed to improve the reporting of SWATs. Discussion: There is a need to develop a strategy to aid teams to identify a suitable SWAT for their host trial populations and a mechanism to communicate SWAT research priorities. Work is needed to increase the awareness of the methodological importance of SWAT research with research teams and develop engagement strategies to increase SWAT activity. Continued collaboration with the HRA is necessary to refine the SWAT approvals process. Conclusion: The coordination PROMETHEUS provided is crucial to increasing the recruitment retention evidence base. The Trial Forge Network will be key to provide ongoing networking and dissemination opportunities.

Indexed as

methodologicalrandomised controlled trialrecruitment and retentionresearch designs and methodsstudy within a trial

Identifiers

PMID41908262
PMCPMC13020921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.